N/A N=18 Treatment

Pseudophakic Astigmatic Reduction With Verion-LenSx Arcuate Incisions

Astigmatism

Bottom Line

View on ClinicalTrials.gov: NCT02763124 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Nov 2019

Primary outcome: Primary: Uncorrected Monocular Distance Visual Acuity — 0.14 logMAR

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Verion-LenSx (Procedure)
Age: Adult, Older Adult · 40+ yrs
Sex: All
Sponsor: Gainesville Eye Associates
Primary completion: Oct 2016

Outcome Measures

Outcome	Result	p-value
PRIMARY Uncorrected Monocular Distance Visual Acuity	0.14	—
SECONDARY Change in Corneal Astigmatism	1.2	—
SECONDARY Change in Refractive Cylinder	1.21	—
SECONDARY Spectacle Independence at Distance	12	—

Summary

To assess the effectiveness of the Verion-LenSx guided arcuate incision technique to reduce astigmatism in a pseudophakic population.

Eligibility Criteria

Inclusion Criteria

Age 40 or older
Willing and able to provide informed consent for participation in the study.

Exclusion Criteria

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02763124). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.